Imperial College London
Portrait Picture

ProfessorHolgerAuner

Faculty of Medicine, Department of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

holger.auner04 Website

 
 
//

Assistant

 

Miss Mandy Sale +44 (0)20 3313 4017

 
//

Location

 

4N7ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Richard:2021:10.1002/ajh.26261,
author = {Richard, S and Chari, A and Delimpasi, S and Simonova, M and Spicka, I and Pour, L and Kriachok, I and Dimopoulos, MA and Pylypenko, H and Auner, HW and Leleu, X and Usenko, G and Hajek, R and Benjamin, R and Dolai, TK and Sinha, DK and Venner, CP and Garg, M and Stevens, DA and Quach, H and Jagannath, S and Moreau, P and Levy, M and Badros, A and Anderson, LD and Bahlis, NJ and Facon, T and Mateos, MV and Cavo, M and Chang, H and Landesman, Y and Chai, Y and Arazy, M and Shah, J and Shacham, S and Kauffman, MG and Grosicki, S and Richardson, PG},
doi = {10.1002/ajh.26261},
journal = {AMERICAN JOURNAL OF HEMATOLOGY},
pages = {1120--1130},
title = {Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk},
url = {http://dx.doi.org/10.1002/ajh.26261},
volume = {96},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Richard,S
AU  - Chari,A
AU  - Delimpasi,S
AU  - Simonova,M
AU  - Spicka,I
AU  - Pour,L
AU  - Kriachok,I
AU  - Dimopoulos,MA
AU  - Pylypenko,H
AU  - Auner,HW
AU  - Leleu,X
AU  - Usenko,G
AU  - Hajek,R
AU  - Benjamin,R
AU  - Dolai,TK
AU  - Sinha,DK
AU  - Venner,CP
AU  - Garg,M
AU  - Stevens,DA
AU  - Quach,H
AU  - Jagannath,S
AU  - Moreau,P
AU  - Levy,M
AU  - Badros,A
AU  - Anderson,LD
AU  - Bahlis,NJ
AU  - Facon,T
AU  - Mateos,MV
AU  - Cavo,M
AU  - Chang,H
AU  - Landesman,Y
AU  - Chai,Y
AU  - Arazy,M
AU  - Shah,J
AU  - Shacham,S
AU  - Kauffman,MG
AU  - Grosicki,S
AU  - Richardson,PG
DO  - 10.1002/ajh.26261
EP  - 1130
PY  - 2021///
SN  - 0361-8609
SP  - 1120
TI  - Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk
T2  - AMERICAN JOURNAL OF HEMATOLOGY
UR  - http://dx.doi.org/10.1002/ajh.26261
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000669628300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 96
ER  -
Download